Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease

被引:22
|
作者
Zhu, Kai [1 ,2 ]
Li, Jun [1 ,2 ]
Wang, Yulin [1 ,2 ]
Lai, Hao [1 ,2 ]
Wang, Chunsheng [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200032, Peoples R China
[2] Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China
基金
美国国家科学基金会;
关键词
IRON-OXIDE NANOPARTICLES; GENE DELIVERY; GROWTH-FACTOR; PLASMID DNA; IN-VIVO; TRACKING; TRANSFECTION; RETENTION; CYTOTOXICITY; EFFICIENCY;
D O I
10.1155/2016/1384658
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cell therapy has attracted increasing attention as a promising treatment strategy for cardiac repair in ischemic heart disease. Nanoparticles (NPs), with their superior physical and chemical properties, have been widely utilized to assist stem cell therapy. With the help of NPs, stem cells can be genetically engineered for enhanced paracrine profile. To further understand the fate and behaviors of stem cells in ischemic myocardium, imaging NPs can label stem cells and be tracked in vivo under multiple modalities. Besides that, NPs can also be used to enhance stem cell retention in myocardium. These facts have raised efforts on the development of more intelligent and multifunctional NPs for cellular application. Herein, an overview of the applications of NPs-assisted stem cell therapy is given. Key issues and future prospects are also critically addressed.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cell therapy of ischemic heart disease:: Hype and hope
    Menasche, P.
    NEW HORIZONS IN CORONARY ARTERY DISEASE, 2007, : 1 - 2
  • [42] Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
    Rodrigo, Sander F.
    van Ramshorst, Jan
    Beeres, Saskia L. M. A.
    Bax, Jeroen J.
    Schalij, Martin J.
    Atsma, Douwe E.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (30) : 3308 - 3327
  • [43] Stem cell repair in ischemic heart disease: An experimental model
    Donald Orlic
    International Journal of Hematology, 2002, 76 : 144 - 145
  • [44] Stem cell repair in ischemic heart disease: An experimental model
    Orlic, D
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 144 - 145
  • [45] Optimizing Stem Cell Function for the Treatment of Ischemic Heart Disease
    Herrmann, Jeremy L.
    Abarbanell, Aaron M.
    Weil, Brent R.
    Manukyan, Mariuxi C.
    Poynter, Jeffrey A.
    Brewster, Benjamin J.
    Wang, Yue
    Meldrum, Daniel R.
    JOURNAL OF SURGICAL RESEARCH, 2011, 166 (01) : 138 - 145
  • [46] Mechanistic Modeling of Nanoparticles-Assisted Surfactant Flood
    Khalilinezhad, Seyyed Shahram
    Mobaraki, Sina
    Zakavi, Mahdi
    Sorkhabadi, Milad Omidvar
    Cheraghian, Goshtasp
    Jarrahian, Khosro
    ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING, 2018, 43 (11) : 6609 - 6625
  • [47] Mesoporous silica nanoparticles-assisted ruthenium(II) complexes for live cell staining
    Jia Wen
    Hui Yan
    Pengyi Xia
    Yongqian Xu
    Hongjuan Li
    Shiguo Sun
    Science China Chemistry, 2017, 60 : 799 - 805
  • [48] Mechanistic Modeling of Nanoparticles-Assisted Surfactant Flood
    Seyyed Shahram Khalilinezhad
    Sina Mobaraki
    Mahdi Zakavi
    Milad Omidvar Sorkhabadi
    Goshtasp Cheraghian
    Khosro Jarrahian
    Arabian Journal for Science and Engineering, 2018, 43 : 6609 - 6625
  • [49] Harnessing the secretome of cardiac stem cells as therapy for ischemic heart disease
    Khanabdali, Ramin
    Rosdah, Ayeshah A.
    Dusting, Gregory J.
    Lim, Shiang Y.
    BIOCHEMICAL PHARMACOLOGY, 2016, 113 : 1 - 11
  • [50] Clathrin-mediated Endocytosis Plays a Key Role in Stem Cell Therapy for Ischemic Heart Disease
    Eguchi, Shunsuke
    Takefuji, Mikito
    Murohara, Toyoaki
    CIRCULATION, 2020, 142